Nexthera Capital »

Ascendis Pharma A S shares owned by Nexthera Capital

Quarter-by-quarter ownership of Ascendis Pharma A S (ASND) shares owned by Nexthera Capital from 13F filings

Historical chart of Nexthera Capital investment in Ascendis Pharma A S

Jan 2017Jul 2017Jan 2018Jul 2018Jan 2019Jul 20192M4M6M60k80k100k120k140k
Value ($)Share countHistorical ASND position of Nexthera Capital Source: stockzoa.comValue ($)Share count

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma A S held by Nexthera Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma A S by Nexthera Capital

Quarter filed Position value Share count Share price at filing
2019-06-30 $6.9M 60k 115.16
2016-12-31 $2.0M 100k 20.24
2016-09-30 $2.9M 146k 20.10

More positions owned by Nexthera Capital

Intercept Pharmaceuticals In
Insmed (INSM)
Audentes Therapeutics
Neurocrine Biosciences (NBIX)
Sarepta Therapeutics (SRPT)
Global Blood Therapeutics In
Immunomedics
Coherus Biosciences (CHRS)
Ascendis Pharma A S (ASND)
Pacira Pharmaceuticals (PCRX)
Urogen Pharma (URGN)
Uniqure Nv (QURE)
Amarin Corporation (AMRN)
Abbvie (ABBV)
Biohaven Pharmaceutical Holding

View all positions for Nexthera Capital

Top funds holding Ascendis Pharma A S

RA Capital Management
Westfield Capital Management Company
venBio Select Advisor
FMR
Artisan Partners Limited Partnership
Henderson Group
Capital Research and Management Company - Division 3
T. Rowe Price Investment Management
T. Rowe Price Associates
Massachusetts Financial Services
Franklin Resources
Invesco
Citadel Advisors
Morgan Stanley
Camber Capital Management

View all funds holding Ascendis Pharma A S